{{Rsnum
|rsid=10276036
|Gene=ABCB1
|Chromosome=7
|position=87550882
|Orientation=plus
|GMAF=0.4357
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 16.8 | 56.6 | 26.5
| HCB | 50.4 | 38.0 | 11.7
| JPT | 33.9 | 48.2 | 17.9
| YRI | 2.7 | 27.2 | 70.1
| ASW | 1.8 | 40.4 | 57.9
| CHB | 50.4 | 38.0 | 11.7
| CHD | 45.9 | 45.0 | 9.2
| GIH | 31.7 | 54.5 | 13.9
| LWK | 5.5 | 27.3 | 67.3
| MEX | 15.8 | 59.6 | 24.6
| MKK | 3.2 | 27.6 | 69.2
| TSI | 20.6 | 43.1 | 36.3
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs10276036
|Name_s=ABCB1: IVS9 ?44a>G
|Gene_s=ABCB1
|Feature=Intron
|Evidence=PubMed ID:19940846
|Annotation=The AUCs of irinotecan, SN-38, SN-38 glucuronide, and APC are influenced by rs3740066, rs2306283, rs35605, rs10276036, and rs717620 .
|Drugs=irinotecan; SN-38
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111619
}}

{{PMID Auto
|PMID=19844206
|Title=Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
|OA=1
}}

{{PMID Auto
|PMID=19961594
|Title=Power of multifactor dimensionality reduction and penalized logistic regression for detecting gene-gene interaction in a case-control study.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10276036
|overall_frequency_n=6732
|overall_frequency_d=10748
|overall_frequency=0.626349
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=68
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}